Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Translational Study of Sorafenib for the Treatment of Chronic Lymphocytic Leukemia Patients

NCT01510756 is registered in ClinicalTrials.gov with Thomas Kipps as lead sponsor.

NCT NCT01510756
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01510756 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Translational Study of Sorafenib for the Treatment of Chronic Lymphocytic Leukemia Patients
Lead sponsor
Thomas Kipps
Phase
Phase 2
Overall status
Terminated
Start date
December 31, 2011
Completion date
December 31, 2014
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia